345 related articles for article (PubMed ID: 28320379)
1. miRNAs associated with prostate cancer risk and progression.
Luu HN; Lin HY; Sørensen KD; Ogunwobi OO; Kumar N; Chornokur G; Phelan C; Jones D; Kidd L; Batra J; Yamoah K; Berglund A; Rounbehler RJ; Yang M; Lee SH; Kang N; Kim SJ; Park JY; Di Pietro G
BMC Urol; 2017 Mar; 17(1):18. PubMed ID: 28320379
[TBL] [Abstract][Full Text] [Related]
2. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.
Casanova-Salas I; Rubio-Briones J; Calatrava A; Mancarella C; Masiá E; Casanova J; Fernández-Serra A; Rubio L; Ramírez-Backhaus M; Armiñán A; Domínguez-Escrig J; Martínez F; García-Casado Z; Scotlandi K; Vicent MJ; López-Guerrero JA
J Urol; 2014 Jul; 192(1):252-9. PubMed ID: 24518785
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
Kumar B; Lupold SE
Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
[TBL] [Abstract][Full Text] [Related]
4. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
Corcoran C; Rani S; O'Driscoll L
Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
[TBL] [Abstract][Full Text] [Related]
5. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
[TBL] [Abstract][Full Text] [Related]
6. miRNAs as novel biomarkers in the management of prostate cancer.
Filella X; Foj L
Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
Gandellini P; Folini M; Zaffaroni N
Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer.
Ghafouri-Fard S; Shoorei H; Taheri M
Gene; 2020 Oct; 759():144995. PubMed ID: 32721477
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?
Andl T; Ganapathy K; Bossan A; Chakrabarti R
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32645914
[TBL] [Abstract][Full Text] [Related]
10. Widespread deregulation of microRNA expression in human prostate cancer.
Ozen M; Creighton CJ; Ozdemir M; Ittmann M
Oncogene; 2008 Mar; 27(12):1788-93. PubMed ID: 17891175
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
[TBL] [Abstract][Full Text] [Related]
12. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
[TBL] [Abstract][Full Text] [Related]
13. [MicroRNAs and prostate cancer].
Yang CH; Zhang CN
Zhonghua Nan Ke Xue; 2010 Sep; 16(9):844-9. PubMed ID: 21171273
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.
Wach S; Nolte E; Szczyrba J; Stöhr R; Hartmann A; Ørntoft T; Dyrskjøt L; Eltze E; Wieland W; Keck B; Ekici AB; Grässer F; Wullich B
Int J Cancer; 2012 Feb; 130(3):611-21. PubMed ID: 21400514
[TBL] [Abstract][Full Text] [Related]
15. Coordinate microRNA-mediated regulation of protein complexes in prostate cancer.
Alshalalfa M; Bader GD; Bismar TA; Alhajj R
PLoS One; 2013; 8(12):e84261. PubMed ID: 24391925
[TBL] [Abstract][Full Text] [Related]
16. Kallikreins are involved in an miRNA network that contributes to prostate cancer progression.
Samaan S; Lichner Z; Ding Q; Saleh C; Samuel J; Streutker C; Yousef GM
Biol Chem; 2014 Sep; 395(9):991-1001. PubMed ID: 25153383
[TBL] [Abstract][Full Text] [Related]
17. miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression.
Fendler A; Jung M; Stephan C; Honey RJ; Stewart RJ; Pace KT; Erbersdobler A; Samaan S; Jung K; Yousef GM
Int J Oncol; 2011 Nov; 39(5):1183-92. PubMed ID: 21769427
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in prostate cancer: Functional role as biomarkers.
Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs associated with metastatic prostate cancer.
Watahiki A; Wang Y; Morris J; Dennis K; O'Dwyer HM; Gleave M; Gout PW; Wang Y
PLoS One; 2011; 6(9):e24950. PubMed ID: 21980368
[TBL] [Abstract][Full Text] [Related]
20. MiRNA targets of prostate cancer.
Deng JH; Deng Q; Kuo CH; Delaney SW; Ying SY
Methods Mol Biol; 2013; 936():357-69. PubMed ID: 23007521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
